CDNA R&D to Revenue
Caredx Inc · R&D to Revenue
CDNA R&D to Revenue
Latest reported16.96%period ending
CDNA Quarterly R&D/Revenue (20.12% → 16.96%)
Latest values, visible window
High-resolution chart · PNG
CDNA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 16.9582% | |
| 18.1954% | |
| 17.8123% | |
| 16.7598% | |
| 19.4165% | |
| 21.874% | |
| 19.0924% | |
| 21.0972% | |
| 21.3419% | |
| 25.9698% | |
| 27.8729% | |
| 28.2772% | |
| 28.7805% | |
| 31.5252% | |
| 28.6099% | |
| 28.1077% | |
| 28.0676% | |
| 27.5511% | |
| 27.8288% | |
| 25.7167% | |
| 25.6591% | |
| 23.7448% | |
| 22.7218% | |
| 23.3731% | |
| 31.4083% | |
| 26.0891% | |
| 24.9742% | |
| 25.2019% | |
| 24.2576% | |
| 21.6073% | |
| 16.0875% | |
| 18.2591% | |
| 19.6151% | |
| 23.9664% | |
| 24.2182% | |
| 24.272% | |
| 25.8841% | |
| 28.3408% | |
| 29.0424% | |
| 23.487% | |
| 29.2772% | |
| 48.1408% | |
| 40.6739% | |
| 37.729% | |
| 35.2083% | |
| 19.6924% | |
| 16.3229% | |
| 15.5696% | |
| 11.6883% | |
| 12.154% | |
| 11.2724% | |
| 11.5073% | |
| 15.503% | |
| 20.1164% |